CompletedNCT00006170
Bupropion and CBT to help women stop smoking
About this title
Read the official source — NCT00006170Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateSeptember 2000
- Recruitment status
- Completed
- Enrollment listed in the registry
- 349
- Sponsor
- University of Pittsburgh
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00006170
- Official title
Show the full official title
Bupropion and Weight Control for Smoking Cessation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pittsburgh, a university.
Did this study involve medication?
Yes. The study involved medication, including Bupropion and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
